Watch Ticker

NextCure, Inc. Common Stock

Go to NextCure, Inc. Common Stock Website

$5.16

-0.04 (-0.77%)

Live

Previous Close

$5.16

Day Range

$4.91 - $5.16

Previous Day Range

$4.8 - $5.29

Market Cap

$13.9 million USD

Day Vol.

15960

Previous Day Vol.

23731

Currency

USD

Primary Exchange

Nasdaq

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product cand...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Nextcure, Inc. - NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

NextCure, a clinical-stage biopharmaceutical company, announced the completion of cohort 1 of the Phase 1 trial for its B7-H4 ADC drug candidate and plans to initiate backfill cohorts in the second half of 2025. The company reported a cash position of approximately $68.6 million.

Related tickers: NXTC.

Read Full Article

Nextcure, Inc. - NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

NextCure, a clinical-stage biopharmaceutical company, announced its participation in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on December 5, 2024.

Related tickers: NXTC.

Read Full Article

Trending Tickers

Please sign in to view